Neuralink: The Biological Margin Call

The Cassandra Files · May 1, 2026 · 16m

Cassandra warned of the horse; we warn of the wire. Neuralink boasts a staggering nine-billion-dollar valuation as of Q1 2026, a figure our empirical analyst, Katie, hails as a triumph of neurotechnology and institutional confidence. But Marcus, our cynical auditor, sees a "rusted spark plug in a flooded engine" – a speculative bubble built on the "capitalization of the mind." Join us as we dissect this monumental valuation, questioning whether it's a miracle of innovation or a ticking biological time bomb, stripping copper from your own walls to pay the electric bill.